Estimated dietary sodium intake in haemodialysis patients using food frequency questionnaires by Gkza, A & Davenport, A
O R I G I N A L A R T I C L E
Estimated dietary sodium intake in haemodialysis
patients using food frequency questionnaires
Anastasia Gkza1 and Andrew Davenport2
1Department of Nutrition, University College London, London, UK and 2UCL Centre for Nephrology, Royal Free
Hospital, University College London, London, UK
Correspondence and offprint requests to: Andrew Davenport; E-mail: andrewdavenport@nhs.net
Abstract
Background: In clinical practice, dietary sodium assessment requires reliable and rapid screening tools. We wished to evalu-
ate the usefulness of food frequency questionnaires (FFQ) in estimating dietary sodium intakes in haemodialysis patients.
Methods: We used the Derby Salt Questionnaire (DSQ), and Scored Sodium Questionnaire (SSQ) to estimate sodium intake.
Body composition was determined by bioimpedance.
Results: In total, 139 haemodialysis patients (95 men) completed the FFQs, with mean6 standard deviation age 67
615 years. The mean FFQ scores were DSQ 3.562.0 and SSQ 68.46 24.5. Men had higher estimated dietary sodium intakes
[DSQ median (range) 3.6 (0.6–10.1) versus female 2.2 (0.5–9.1), P¼0.007)]. Younger patients and those aged >75 years had the
higher SSQ dietary sodium scores; 70.76 27.8 and 76.86 24.6 versus those aged 55–75 years, 61.86 22.3, P¼0.04. Patients
with greater estimated sodium intake had higher extracellular water (ECW) to intracellular water (ICW) ratios pre-dialysis
[75.1612.5 versus 67.76 4.8, P<0.001] and ECW excess pre-dialysis [1.8 (1.5–2.6) versus 1.3 (0.8–2.0) L, P<0.05]. Mean arterial
pressure (MAP) and inter-dialytic weight gains did not differ; however, the fall in MAP during dialysis was lower in the
higher estimated dietary sodium group (0.96 13.7% versus 6.56 14.1%, P¼0.04).
Conclusions: Both questionnaires were acceptable to patients and identified higher estimated dietary sodium intake for
men, those with greater ECW and, somewhat surprisingly, we found that older patients had a greater dietary sodium intake
than expected.
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Introduction
Although sodium is essential for life, and determines extracel-
lular water (ECW), excessive sodium retention leads to ECW
expansion and peripheral oedema in patients with heart failure
and nephrotic syndrome. Sodium stores in the body have been
shown to increase with age, and are greater in patients with
hypertension [1, 2]. Short-term trials of lowering dietary sodium
intake have been reported to reduce blood pressure [3].
Patients with chronic kidney disease (CKD) are at an
increased risk of sodium retention as the kidney fails to
adequately excrete sodium [4]. Sodium also plays a major role
in determining thirst, and therefore fluid intake. As such,
Received: January 21, 2017. Editorial decision: April 4, 2017
VC The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact journals.permissions@oup.com
715
Clinical Kidney Journal, 2017, vol. 10, no. 5, 715–720
doi: 10.1093/ckj/sfx037
Advance Access Publication Date: 22 May 2017
Original Article
sodium balance has been linked to inter-dialytic weight gains
(IDWGs) in haemodialysis patients [5, 6], ECW expansion and
hypertension [7–9].
Salt intake with the modern Western-type diet has been esti-
mated up to 12 g/day (4.6 g or 200 mmol of sodium) [10]. Clinical
guideline groups such as the National Kidney Foundation Kidney
Dialysis Outcome Quality Initiative and European Best Practice
Clinical Guidelines have recommended that kidney dialysis
patients should limit their dietary salt intake to 5 g/day (2.0 g or
85 mmol of sodium) [11, 12].
Twenty-four-hour urine collections for sodium excretion
have been used as the standard method to assess dietary
sodium intake, but even these have been reported to show
marked intra-patient variation even in a controlled environ-
ment [13]. However, patients with kidney failure treated by dial-
ysis may be anuric or oliguric, and as such other methods are
required to assess dietary sodium intake. This has led to the
development of food frequency questionnaires (FFQs), to esti-
mate dietary sodium intake. As such we wished to evaluate the
usefulness of two of these FFQs in clinical practice, the ‘Derby
Salt Questionnaire’ (DSQ) [14] and a modified ‘Scored Sodium
Questionnaire’ (SSQ) [15], to estimate dietary sodium intake and
to determine whether there was any association between DSQ
and SSQ scores and blood pressure, IDWGs and volume status
in haemodialysis patients.
Materials and methods
We audited the usefulness of two FFQs (Supplementary data)
designed for UK dietary sodium intake between May 2015 and
June 2015 in a cohort of adult patients established on haemo-
dialysis, attending for thrice weekly routine outpatient treat-
ments. Prior to starting dialysis patients were reviewed
by dieticians and given advice to restrict dietary salt intake to
<5 g/day. All patients in the dialysis centre were asked to com-
plete the FFQs. However, patients were excluded if they were
not in a stable state, for example, if they had only recently
started dialysis, or discharged from hospital. Patients who were
required to self-report the FFQs and were unable to read or
understand the FFQs provided were excluded from the study.
Questionnaires were administered on the same day by a renally
trained dietician, who also recorded patient self-reported esti-
mates of daily fluid intake and urine output.
Although several sodium targeted FFQs have been developed
based on diets in other countries, only the DSQ [14] and a modi-
fied SSQ [15] have been adapted for a UK diet. Both FFQs have pre-
viously been validated in CKD cohorts in single centres [14, 15].
Analysis from previous studies using the SSQ reported that a cut-
off score of 65 had the greatest sensitivity and specificity to iden-
tify patients with CKD with a high dietary sodium intake, which
equated to a dietary sodium intake of approximately >6.0 g/day
[15]. On the other hand, the DSQ aims to estimate the dietary salt
intake, but does not have a cut-off value based on sensitivity
and specificity identifying patients with a high dietary sodium
intake [14].
Details of patient demographics, medications and dialysis
prescriptions and dialysis sessions were obtained from the
hospital computerized renal database. Anthropomorphic meas-
urements of height and weight were recorded (Marsden,
Rotherham, UK). To assess ECW and total body water (TBW),
multi-segmental bioimpedance measurements were obtained
prior to and post mid-week haemodialysis session (InBody,
Seoul, South Korea) [16, 17], and the post-dialysis bioimpedance
assessment was used to obtain body composition
measurements. ECW excess was calculated as the difference in
bioimpedance measured ECW and the ECW estimated from the
measured intracellular water (ICW), assuming a normally
hydrated state. Urea generation was determined from the pre-
and post-haemodialysis serum urea concentrations,
bioimpedance-derived TBW, divided by the inter-dialytic inter-
val, and then adjusted to 24 h. Haemodialysis machines were
regularly serviced and dialysate sodium checked [18, 19].
Statistical methods
Statistical analysis was by standard parametric or non-
parametric testing, and analysis of variance (ANOVA) with
appropriate post hoc testing. Correlation with the FFQ scores was
by Pearson or Spearman correlation (Prism 6.0, Graph Pad, San
Diego, CA, USA), and all variables with P<0.01 were entered into
a multivariable model, along with variables thought to be clini-
cally relevant and analysed with SPSS (SPSS 21, University of
Chicago, Chicago, IL, USA) using a step-backward approach
eliminating variables that were not significant (P> 0.05) in the
model, unless they improved model fit. We compared the two
FFQ scores by Bland Altman analysis and kappa scores (Analyse
It v 3.0, Leeds, UK). Data are reported as mean6 standard devia-
tion, median and range or interquartile range or percentage.
Ethics
The standard of care of dialysis patients under the University
Hospital includes pre- and post-haemodialysis bioimpedance
measurements and the administration of self-reported salt
FFQs by the dietetic team to patients. We audited the results of
FFQ assessments and body composition. Ethical approval for
the retrospective audit fulfilled UK national health service
(NHS) clinical service development and audit (UK NHS guide-
lines for clinical audit and service development (http://www.
hra.nhs.uk/documents/2013/09/defining-research.pdf), and all
patient data was anonymized.
Results
In total, 139 patients (95 men, 44 women), mean age
67615 years, returned FFQs. The prevalence of diabetes melli-
tus, hypertension and cardiovascular disease was 51.1%, 83.5%
and 36%, respectively. Thirty-eight patients were excluded, as
they were either recently established on dialysis or had been
discharged from hospital, or were unable to read and under-
stand English. North London has a multi-ethnic population, and
we studied 70 Caucasoid, 37 South Asian, 22 African-Afro-
Caribbean and 10 patients of indeterminate ethnicity. The
mean dialysis vintage was 416 45 months, with 65.5% of partici-
pants reporting residual renal function of >200 mL. The mean
IDWG was 2.66 1.8%, with 89 patients (65.9%) having an IDWG
of <3%, and 46 subjects (34.1%) with IDWG of 3%.
Patients found the DSQ relatively easy to complete, requiring
approximately 5–10 min. However, the SSQ is more lengthy and
detailed, and on average took around 15 min to complete and 12
patients declined to fill out the SSQ, reporting tiredness. The
mean SSQ score for all subjects was 68.46 24.5 and the mean
DSQ score 3.56 2.0, and there was a positive correlation
between the two FFQs (Figure 1). Bland Altman analysis (using
DSQ score  10) showed no systematic bias between the two
FFQs, mean bias 33.9 (95% limits of agreement, 6.0 to 72.7) and
kappa analysis 0.15. Taking patients with an increased dietary
sodium intake, an estimated dietary intake of > 5 g salt/day
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based on the DSQ, then 27 of these 28 patients also had
increased dietary sodium intake, as judged by an SSQ score of
> 65.
There were no differences in estimated dietary sodium
intake between non-diabetic and diabetic patients [SSQ median
67 (53–85) versus 68 (51–83) and DSQ 3.1 (2.1–4.8) versus 3.4 (2.0–
5.4)], those with no history of hypertension and hypertensive
patients [SSQ 62 (39–76) versus 68 (54–85) and DSQ 2.8 (2.1–5.0)
versus 3.3 (2.0–4.8)], and those with no cardiovascular disease
and those with ischaemic heart disease [SSQ 68 (54–86) versus
67 (53–78) and DSQ 3.3 (2.2–4.9) versus 3.2 (1.9–4.4)].
We divided patients into groups based on FFQ estimation of
dietary sodium intake; two groups for the SSQ, as high (score
>65) and low or moderate (<65) [15], and as there was no pre-
determined cut-off for the DSQ, we divided patients into three
similar-sized groups, of low, moderate and high dietary sodium
[score <2.5 (low), 2.5–4.0 (moderate) and >4.0 (high), respec-
tively]. Dietary sodium intake was greater for men than women,
lower for patients aged 55–75 years, but was not different
between ethnic groups (Table 1).
Self-reported fluid intake was greater for the SSQ high-esti-
mated dietary sodium group, although there were no differen-
ces in self-reported urine volume between the SSQ groups. The
highest DSQ estimated dietary sodium group reported greater
urine output (Table 2). There were no differences in pre-dialysis
weight, blood pressure, serum sodium after adjustment for glu-
cose interference, dialysis adequacy or dialysate sodium con-
centration, or estimated urea nitrogen generation between
groups. IDWG did not differ between groups, but there was a
greater fall in systolic blood pressure in the low/moderate SSQ
estimated dietary sodium group (Table 2).
Although weight was similar between the two SSQ groups,
the higher estimated dietary sodium group tended to have both
greater ICW and ECW, and consequently greater TBW and body
cell mass (BCM), with more muscle and less fat, although these
differences were not statistically different (Table 3). To adjust
for differences in body size we compared the ratio of ECW to
ICW, and also estimated ECW. Taking a cut-off of 5 g/day with
the DSQ and > 65 for the SSQ, patients with higher dietary
sodium intakes had greater ECW both pre- and post-dialysis,
although this was only statistically significant with the DSQ
(Table 4).
There were simple correlations between the change in blood
pressure during dialysis and estimated dietary sodium intake
[DSQ change in mean arterial pressure (MAP), R¼0.23, P< 0.01,
and SSQ R ¼0.29, P¼ 0.001], and percentage body fat (DSQ R ¼
0.293, P¼ 0.001 and SSQ R¼0.228, P¼ 0.013). There were also
correlations between DSQ scores and TBW (R¼ 0.29, P¼ 0.001)
and BCM (R¼ 0.26, P¼ 0.003). After adjusting pre-dialysis serum
sodium for glucose [19], there was a weak negative correlation
between pre-dialysis serum sodium and self-reported fluid
intake (R¼0.2, P< 0.05). There was no correlation between FFQ
score and ‘dialysis vintage’ (DSQ R¼ 0.06, P¼ 0.5 and SSQ
R¼ 0.12, P¼ 0.17).
We developed a step-backward multivariable regression
model to identify independent predictors of FFQ based on esti-
mated sodium intake. The DSQ score was associated with the
post-dialytic BCM (b¼ 0.161, P< 0.001) and urea nitrogen genera-
tion (b¼0.002, P< 0.05), after adjusting for pre-dialytic
ECW/TBW ratio, intradialytic change in MAP change, urine out-
put and fluid intake (model adjusted R2 ¼ 0.18). Meanwhile, for
the SSQ score as the dependent variable, there was an associa-
tion with intradialytic change in MAP (b ¼0.341, P< 0.05), male
gender (b¼ 12.7, P< 0.05) and pre-dialysis percentage body fat
(b¼0.45, P< 0.05), after adjusting for urea nitrogen generation
and fluid intake (model adjusted R2 ¼ 0.17). However, these
models could only account for <20% of the variance in esti-
mated dietary sodium intake by the FFQs.
Discussion
Loss of renal function reduces the ability of the body to excrete
a sodium load, and as such one of the key goals of haemodialy-
sis treatments is to restore sodium balance. ECW overload is
now recognized as a major risk for early mortality in haemodial-
ysis patients [20, 21]. Sodium intake stimulates thirst, and as
such dialysis patients are advised to restrict dietary sodium to
reduce IDWGs and ultrafiltration requirements [4, 5]. Patients
do not always comply with dietary advice [6, 22], and due to
time constraints in clinical practice, dietetic interventions are
best targeted to patients with problems [6, 23], rather than try-
ing to briefly review all patients in large centres. This has led to
the development of FFQs to estimate dietary sodium intake,
designed to screen patients and select out those with higher
dietary sodium intake [14, 15]. These questionnaires have been
validated in cohorts of patients with CKD [14, 15], assuming that
in the steady state patients are in a neutral sodium balance, so
that urinary sodium excretion approximates dietary sodium
ingestion. However, FFQs have not been validated in haemodial-
ysis patients as estimation of dietary sodium intake from uri-
nary sodium excretion is not possible, as the great majority of
patients are either oliguric or anuric.
Fig. 1. Simple univariate correlation between the SSQ and the DSQ.
Table 1. Patient demographics and DSQ [13], and modified SSQ
scores [14]
DSQ score SSQ score
Men 3.6 (0.6–10.1), P¼ 0.007 72.0 (10.5–136.5), P¼ 0.009
Women 2.2 (0.5–9.2) 58.8 (10.0–153.0)
Age <55 years 3.6 (0.8–10.1) 70.7 6 27.8
Age 55–75 years 2.5 (0.9–7.2) 61.8 6 22.3
Age >75 years 3.6 (0.5–9.2), P¼ 0.011 76.8 6 24.6, P¼ 0.040
Caucasoid 3.2 (0.9–8.8), P¼ 0.16 69.0 6 25.5, P¼ 0.61
South Asian 2.5 (0.6–7.9) 67.6 6 19.8
Afro-Caribbean 3.9 (0.8–10.1) 68.9 6 29.3
Other ethnicity 3.5 (0.5–8.1) 72.8 6 33.3
Data expressed as mean6 standard deviation or median and range. P-values
refer to comparison of genders, age and ethnicity groups.
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FFQs are designed to provide an estimate of dietary sodium
intake. As such in our study the mean SSQ and DSQ scores were
68.4 and 3.5, respectively, which according to previous studies
using the SSQ scoring system, would suggest that the majority
of patients were ingesting >6.0 g salt/day [15], whereas the DSQ
score would suggest that the majority were taking around 3.5 g
salt/day [14], indicating good compliance with dietary recom-
mendations of 5 g salt/day [4]. There was no systematic bias
between the two scores; however, as the FFQs have different
scoring scales, agreement between the scores was mild and we
did not perform a formal validation study, so whether one FFQ
over- or underestimated dietary sodium intake compared with
the other remains speculative. Sodium intake in healthy hae-
modialysis patients, living in economically developed Western
Table 2. Patients divided into high dietary sodium intake by FFQs: DSQ [14] and a modified SSQ [15]
Variable All SSQ <65 SSQ 65 DSQ <2.5 DSQ 2.5–4 DSQ >4
Number 139 60 67 47 46 46
Oral intake 0.88 (0.2–3.5) 0.8 (0.2–2.5) 1.0 (0.2–3.5)* 0.8 (0.25–2.15) 0.8 (0.3–2.5) 1.0 (0.25–2.15)*
UO 0.2 (0–2.5) 0.2 (0–2.5) 0.2 (0–2.5) 0.15 (0–2.0) 0.15 (0–2.5) (0.590–2.51)*
PreNa 139 (127–151) 139 (124–145) 139 (133–151) 139 (127–146) 140 (132–151) 138 (132–144)
PostNa 139 (130–145) 139 (130–145) 139 (135–144) 137 (136–138) 137 (136–140) 138 (136–140)
DialNa 137 (136–143) 137 (136–140) 137 (136–143) 137 (136–138) 137 (136–140) 138 (136–143)
URR 766 6 7566 7765 7766 766 5 746 7
UGR 6.9 (2.3–21.4) 7.1 (2.7–14.5) 7.0 (2.3–21.4) 7.4 (3.3–14.5) 7.5 (2.7–21.4) 6.6 (2.6–11.7)
PreSBP 1406 26 145626 137626 141627 1376 24 1466 27
PreDBP 746 15 76613 72616 76614 726 14 736 16
PostSBP 1326 24 132624 132624 129624 1296 22 1396 26
PostDBP 716 14 71614 72615 70612 726 15 726 15
DSBP 86 22 13622 5622* 12620 86 21 56 26
DDBP 26 12 4613 0611 6613 06 11 06 11
%DSBP 4.66 15.5 8.0613.9 2.1616.2* 7.4613.7 4.46 14.9 1.96 17.6
%DDBP 1.56 17.4 4.1619.8 0.9615 6.1619.9 1.46 15.9* 0.206 15.7*
PreWt 72.46 15.6 72.2614.2 72.4613.5 70.2614.7 73.46 15.3 73.66 17.1
PostWt 70.56 15.5 70.2614.5 70.6617.0 68.1614.8 71.76 15.2 71.86 16.5
IDWG 1.7 (1.6 to 6.4) 1.7 (1.6 to 5.1) 1.9 (0.1–6.4) 1.8 (1.6 to 5.3) 1.8 (0.4 to 5.7) 1.6 (0.1–6.4)
%IDWG 2.5 (4.5 to 13.6) 2.4 (2.8 to 13.6) 2.6 (0.2–13.6) 2.7 (2.8 to 13.6) 2.5 (4.5 to 13.6) 2.5 (0.2–5.6)
DSQ score<2.5 (low), 2.5–4.0 (moderate) and>4.0 (high), and SSQ high sodium65 and moderate/low<65. Self-reported daily fluid intake (Oral intake) L/day, urine out-
put (UO) L/day, urea nitrogen generation rate (UGR) gN/kg/day, serum sodium pre-dialysis (PreNa) and post-dialysis (PostNa) and dialysate sodium (DialNa) mmol/L,
dialysis urea reduction ratio (URR) in %, systolic blood pressure (SBP) and diastolic blood pressure (DBP) pre- and post-dialysis, and absolute difference (D) or percentage
difference (%D) between pre- and post-pressures mmHg, pre- and post-dialysis weight (Wt) kg, inter-dialytic weight gain (IDWG) kg and percentage IDWG (%IDWG).
Data expressed as mean6 standard deviation or median and range, or percentage. *P<0.05, **P<0.01 lowest score group versus highest group.
Table 3. Multi-frequency whole-body bioimpedance measurements pre- and post-mid-week haemodialysis session
Variable All SSQ <65 SSQ 65 DSQ <2.5 DSQ 2.5–4 DSQ >4
Pre-dialysis
TBW (L) 37.96 9.2 36.76 8.8 39.36 10 34.76 8.0 39.06 10.3 40.16 8.6*
ECW (L) 15.36 3.7 14.86 3.5 15.96 4.0 13.96 3.2 15.86 4.0 16.36 3.4*
ICW (L) 22.66 5.7 21.96 5.4 23.56 6.1 20.86 4.8 23.36 6.4 23.86 5.3*
Post-dialysis
BMI (kg/m2) 25.96 5.0 25.6 (14–37) 25 (12–44) 25.86 4.5 26.16 5.3 25.66 5.4
TBW (L) 36.26 8.5 35.26 8.5 37.26 8.7 33.26 8.1 36.96 8.4 38.46 8.2*
ECW (L) 14.36 3.4 13.96 3.4 14.76 3.5 13.16 3.3 14.66 3.3 15.36 3.2*
ICW (L) 21.96 5.2 21.36 5.2 22.56 5.4 22.66 5.7 21.96 5.4 23.56 6.1*
%BFM 20.6 (8–55.2) 21.5 (7–55.2) 19.2 (8–54.8) 21.6 (7–47.8) 22.9 (7–54.8) 18.4 (8–55.2)
FFM (kg) 49.16 11.4 47.76 11.5 50.56 11.8 45.26 10.9 50.36 11.4 52.16 11.1*
SMM (kg) 26.56 6.8 25.76 6.8 27.36 7.1 24.36 6.4 27.16 6.8 28.26 6.7*
BCM (kg) 31.36 7.5 30.56 7.5 32.26 7.7 28.96 7.1 31.96 7.5 33.16 7.3*
Body mass index (BMI), total body water (TBW), extracellular water (ECW) and intracellular water (ICW), and percentage body fat mass (%BFM), fat free mass (FFM),
skeletal muscle mass (SMM) and body cell mass (BCM). Patients were divided according to FFQ assessment of dietary sodium intake, by DSQ [14] and a modified SSQ
[15]. Data expressed as mean6 standard deviation or median and interquartile range. *P<0.05 highest score versus lowest score group.
Table 4. Assessment of hydration status in patients pre- and post-
haemodialysis, using the cut-offs for high dietary sodium intake of
5 g/day for the DSQ [14] and the modified SSQ [15]
DSQ <5 DSQ 5 SSQ <65 SSQ >65
Pre-ECW/ICW 67.764.8 75.16 12.5*** 68.264.9 68.164.6
Post-ECW/ICW 68.164.3 68.36 17.1* 65.663.8 65.865.0
Pre-ECW
excess (L)
1.3 (0.8–2.0) 1.8 (1.5–2.6)* 1.2 (0.8–1.9) 1.3 (0.8–2.0)
Post-ECW
excess (L)
0.9 (0.3–1.7) 1.4 (0.8–2.1)* 0.8 (0.3–1.4) 1.0 (0.2–1.8)
Extracellular water (ECW), intracellular water (ICW) and ECW excess defined as differ-
ence in measured ECW to that predicted from measured ICW. Data expressed as
mean6standard deviation or median and interquartile range. *P<0.05, **P<0.01,
***P<0.001 higher score versus lower score group.
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societies, has been estimated to be about 150–250 mmol/day
(7.5–12.5 g salt/day) [23], and although we cannot exclude
deliberate under-reporting, we believe that our study partici-
pants have indeed a relatively low sodium intake. Our mean
IDWG of 1.7 kg and %IDGW of 2.6% is lower than a target of 3–5%
suggested by North American authors [24], which would sup-
port potential over-reporting of dietary sodium intake with the
SSQ. In keeping with previous reports, we found that men had
significantly higher estimates of sodium intake than women
[14, 15]. Although healthy people from the ethnic minorities
have a higher dietary sodium intake compared with
Caucasoids, we found no difference between our major ethnic
groups, which is in keeping with an earlier report comparing
Caucasoids and African-Americans with CKD [25]. However,
patients who were unable to read and understand English were
excluded from the study, and as these patients were predomi-
nantly from ethnic minority groups, we cannot exclude a differ-
ence in dietary sodium intake in our ethnic minority patients.
Although we had expected to find that sodium intake would
be highest in our younger patients and then fall with age, as
older patients generally have reduced appetites and lower calo-
rie intake, we found that older patients consumed more sodium
than the middle-aged cohort. This is probably now due to the
increased numbers of frail elderly patients treated by dialysis,
who are no longer able to cook fresh food for themselves but
increasingly rely on ready and pre-prepared meals that have
higher sodium content [26]. In our dialysis population, elderly
patients residing in nursing homes or elderly residential homes
typically did not receive low sodium meals.
Sodium content in these meals was often increased by the
addition of gravy and other sauces. Elderly female patients liv-
ing independently were much more likely to cook their own
food, but a proportion of elderly independent patients also
relied on the delivery or pre-cooked meals, and again there was
no low sodium food option.
Sodium intake is linked to thirst, and our patients with
higher estimated sodium intakes also had significantly higher
self-reported fluid intake [23], and there was an association
between pre-dialysis serum sodium and self-reported fluid
intake, with a lower serum sodium associated with greater fluid
intake. Interestingly, estimated higher sodium intake was asso-
ciated with greater self-reported urine output. We used bioim-
pedance assessments to determine body composition [27–29],
and expected that larger patients with greater muscle mass
would generally eat more, and so have a higher dietary sodium
intake. Although there was a trend for increasing body size and
dietary sodium intake with the DSQ, there was no difference
between the two SSQ groups. This may have been due to the rel-
atively greater sodium intake compared with calories in our eld-
erly frail patients. As such, by using the FFQs we were not able
to demonstrate that patients with increased estimated dietary
sodium intake had higher IDWGs, or systolic hypertension,
which is in line with a previous study using dietary recall to
estimate sodium intake [30]. However, we did find that for those
patients estimated to eat 5 g salt/day using the DSQ had greater
ECW, either as a ratio to ICW or as an estimate of ECW overhy-
dration. In addition, it is now recognized that increased sodium
intake does not necessarily lead to increased urinary sodium
excretion, and that sodium can exchange for intracellular potas-
sium and accumulate in tissue matrix without any correspond-
ing changes in fluid status, the so-called non-osmotic sodium
balance [1, 31, 32]. Recent studies have reported that sodium is
removed not only from the ECW but also from tissue stores dur-
ing haemodialysis [32], and as such patients with lower
amounts of sodium in the body may be more vulnerable to
intra-dialytic hypotension, which may account for our finding
of smaller changes in blood pressure during dialysis in those
with higher estimates of sodium intakes. The associations
between the FFQ scores and male sex, BCM, ECW and nitrogen
protein intake would support these questionnaires identifying
patients with greater dietary sodium intake.
In our clinical audit, we found that patients were generally
willing to complete the questionnaires. The DSQ was found to
be shorter and easier to complete, whereas the SSQ took longer
and was found more difficult to complete, especially by the
older patient, although there is now an abridged form of the
SSQ [33]. Self-administration questionnaires could not be com-
pleted by those with visual impairment, or those who could not
read or understand written English. Patients found the shorter
DSQ easier to complete. Unlike previous studies on dietary
sodium assessment in haemodialysis patients we did not col-
lect full dietary histories to be able to reliably estimate dietary
sodium intake, and compare sodium intake to protein or calo-
rific intake, and as such our results must be considered as based
on patient self-reporting [30]. We found that discrimination
appeared to be generally greater with the DSQ score, in terms of
association between estimated dietary sodium intake with
patient physique, ECW excess and systolic blood pressure, and
as such further studies are required to determine whether a dif-
ferent cut-off value for the SSQ would improve discrimination.
If the SSQ questionnaire took longer to complete, then the reli-
ability of patient self-reporting would have been lessened. Both
the dietary questionnaires we used have been developed for a
UK-based population, and such would not necessarily be appli-
cable for different populations, without appropriate
modification.
Dietary sodium assessment requires reliable and rapid
screening tools. The questionnaires identified higher estimated
dietary sodium intake for men, those who reported greater oral
fluid intake, patients with greater ECW excess and BCM, which
would all suggest that these FFQs can identify haemodialysis
patients with higher dietary sodium.
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